Business Description
Redhill Biopharma Ltd
NAICS : 325412
ISIN : US7574681034
Share Class Description:
RDHL: ADRDescription
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.04 | |||||
| Debt-to-Equity | 9.15 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -17.85 | |||||
| Beneish M-Score | 10.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -75.8 | |||||
| 3-Year EPS without NRI Growth Rate | 72.1 | |||||
| 3-Year FCF Growth Rate | 63.5 | |||||
| 3-Year Book Growth Rate | -80.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.72 | |||||
| 9-Day RSI | 43.94 | |||||
| 14-Day RSI | 44.68 | |||||
| 6-1 Month Momentum % | -29.15 | |||||
| 12-1 Month Momentum % | -2.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.74 | |||||
| Quick Ratio | 0.56 | |||||
| Cash Ratio | 0.34 | |||||
| Days Inventory | 660.76 | |||||
| Days Sales Outstanding | 145.86 | |||||
| Days Payable | 417.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -173.7 | |||||
| Shareholder Yield % | 555.27 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.18 | |||||
| Operating Margin % | -339.59 | |||||
| Net Margin % | 945.36 | |||||
| FCF Margin % | -329.47 | |||||
| ROE % | 2731.76 | |||||
| ROA % | 191 | |||||
| ROIC % | -82.71 | |||||
| 3-Year ROIIC % | -27.85 | |||||
| ROC (Joel Greenblatt) % | 3949.83 | |||||
| ROCE % | 1398.28 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.02 | |||||
| PE Ratio without NRI | 0.02 | |||||
| PS Ratio | 0.17 | |||||
| PB Ratio | 167.71 | |||||
| EV-to-EBIT | 0.07 | |||||
| EV-to-EBITDA | 0.03 | |||||
| EV-to-Forward-EBITDA | -3.75 | |||||
| EV-to-Revenue | 0.67 | |||||
| EV-to-Forward-Revenue | 1.37 | |||||
| EV-to-FCF | -0.2 | |||||
| Earnings Yield (Greenblatt) % | 1428.57 | |||||
| FCF Yield % | -172.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RDHL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redhill Biopharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.395 | ||
| EPS (TTM) ($) | 504.826 | ||
| Beta | 5.27 | ||
| Volatility % | 367.13 | ||
| 14-Day RSI | 44.68 | ||
| 14-Day ATR ($) | 0.40535 | ||
| 20-Day SMA ($) | 8.2295 | ||
| 12-1 Month Momentum % | -2.91 | ||
| 52-Week Range ($) | 6.8 - 82 | ||
| Shares Outstanding (Mil) | 1.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Redhill Biopharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Redhill Biopharma Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Redhill Biopharma Ltd Frequently Asked Questions
What is Redhill Biopharma Ltd(RDHL)'s stock price today?
The current price of RDHL is $8.05. The 52 week high of RDHL is $82.00 and 52 week low is $6.80.
When is next earnings date of Redhill Biopharma Ltd(RDHL)?
The next earnings date of Redhill Biopharma Ltd(RDHL) is 2024-11-14 Est..
Does Redhill Biopharma Ltd(RDHL) pay dividends? If so, how much?
Redhill Biopharma Ltd(RDHL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers